BlackBerry is a pass, says RBC

Investors should still be in a wait-and-see mode when it comes to Canadian tech company BlackBerry (TSX:BB). That’s according to RBC Capital analyst Paul Treiber who on June 25 delivered an update to clients on BlackBerry after the company’s fiscal first quarter earnings.

Software and security business BlackBerry reported its Q1 fiscal 2021 financials on June 24, posting a net loss of $636 million or $1.14 per share for the three-month period ended May 31, 2020. That compared to a loss of $35 million or $0.06 per share a year earlier. Revenue for the quarter was $206 million, down from $247 million a year ago and down from $282 million for the previous quarter. (All figures in US dollars except where noted otherwise.)

The quarter also saw BlackBerry get hit by a $594-million goodwill impairment charge in connection with its enterprise cybersecurity wing Spark, while management said it would not be providing guidance for its fiscal 2021, appealing to uncertainty in the global economy due to the COVID-19 pandemic.

CEO John Chen said BlackBerry’s QNX business was affected by macro headwinds in the auto sector as well as the embedded tech space, although Chen added that he’s starting to see signs of a recovery.

“On the enterprise front, we saw good demand from customers who recognized the necessity for BlackBerry’s security, business continuity, and productivity solutions in an
increasingly remote working environment. BlackBerry is capitalizing on the secular
trends of securing and connecting endpoints,” said Chen in a press release.

In his report, Treiber maintained his “Hold” rating and $5.00 target price for BlackBerry, which at the time of publication represented a projected 12-month return of 1.6 per cent.

Year-to-date, BlackBerry is down 24 per cent.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: bb
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

8 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

9 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

10 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

24 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

1 day ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 days ago